High-cost healthcare users in Ontario, Canada: demographic, socio-economic, and health status characteristics
Rosella LC, Fitzpatrick T, Wodchis WP, Calzavara A, Manson H, Goel V. BMC Health Serv Res. 2014; 14:532. Epub 2014 Oct 31.
Publications
A validation study of administrative data algorithms to identify patients with parkinsonism with prevalence and incidence trends
Butt DA, Tu K, Young J, Green D, Wang M, Ivers N, Jaakkimainen L, Lam R, Guttma M. Neuroepidemiology. 2014;43(1):28-37. Epub 2014 Oct 16.
Use of acute care hospital services by immigrant seniors in Ontario: a linkage study
Ng E, Sanmartin C, Tu J, Manuel D. Health Rep. 2014; 25(10):15-22.
Use of mental healthcare for nonpsychotic conditions by immigrants in different admission classes and by refugees in Ontario, Canada
Durbin A, Lin E, Moineddin R, Steele L, Glazier R. Open Medicine. 2014; 8(4):e136-46. Epub 2014 Oct 28.
Effect of a postdischarge virtual ward on readmission or death for high-risk patients: a randomized clinical trial
Dhalla IA, O'Brien T, Morra D, Thorpe KE, Wong BM, Mehta R, Frost DW, Abrams H, Ko F, Van Rooyen P, Bell CM, Gruneir A, Lewis GH, Daub S, Anderson GM, Hawker GA, Rochon PA, Laupacis A. JAMA. 2014; 312(13):1305-12.
A population-based study of the resource utilization and costs of managing resectable non-small cell lung cancer
Mahar AL, Coburn NG, Johnson AP. Lung Cancer. 2014; 86(2):281-7. Epub 2014 Sep 20.
WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys
Holloway KA, Henry D. PLoS Med. 2014; 11(9):e1001724. Epub 2014 Sep 16.
Quantifying comorbidity in individuals with chronic obstructive pulmonary disease: a population study
Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Eur Respir J. 2015; 45(1):51-9. Epub 2014 Aug 20.
Impact of living alone on the care and outcomes of patients with acute stroke
Reeves MJ, Prager M, Fang J, Stamplecoski M, Kapral MK. Stroke. 2014; 45(10):3083-5. Epub 2014 Aug 19.
Real world costs and cost-effectiveness of rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
Khor S, Beca J, Krahn M, Hodgson D, Lee L, Crump M, Bremner KE, Luo J, Mamdani M, Bell CM, Sawka C, Gavura S, Sullivan T, Trudeau M, Peacock S, Hoch JS. BMC Cancer. 2014; 14:586. Epub 2014 Aug 12.